-
Regenerative Orthopedics & Sports Medicine partners on rotator cuff research
Washington, D.C.-based Regenerative Orthopedics & Sports Medicine has partnered with the Orthobiologics Research Initiative to support nonsurgical orthopedic research aimed at treating partial-thickness rotator cuff tears using cutting-edge orthobiologic procedures. -
Full Circle Orthopedics expands regenerative medicine services
Phoenix-based Full Circle Orthopedics is expanding its regenerative medicine program, according to an Oct. 22 news release. -
11 places adding the BEAR implant since 2023
Since the start of 2023, several practices and health systems have added the Bridge-Enhanced ACL restoration procedure, which uses a patient's blood to help heal the injury. -
Bone Biologics adds to board of directors
Bone Biologics appointed Phillip Meikle to its board of directors, according to an Oct. 21 news release. -
Spine patient sues over tainted bone graft: 5 notes
A woman is suing Elutia, formerly Aziyo Biologics, after contracting tuberculosis from a product used in an April 2021 spine surgery, The Atlanta Journal-Constitution reported Oct. 17. -
Tetrous earns patent for bone fiber implants
Tetrous, a start-up focused on bone-to-tendon healing following orthopedic surgery, has earned a fourth patent related to its EnFix family of demineralized cortical bone fiber implants. -
5 spine, orthopedic biologic companies to know
Here are five spine and orthopedic companies that specialize in regenerative medicine and biologic implants. -
Regenity Biosciences earns FDA clearance for knee implant
Regenity Biosciences earned FDA 510(k) clearance for RejuvaKnee, a collagen-based meniscus implant designed for reinforcement and repair of soft tissue injuries of the meniscus, the company said Oct. 8. -
RTI Surgical to acquire biologic company
RTI Surgical, a healthcare biologics company, plans to acquire Collagen Solutions, according to an Oct. 7 news release. -
6 orthobiologics updates
From new research to FDA nods, here are six key updates in the spine and orthopedic regenerative medicine space since Sept. 1. -
Spinal bone regeneration biologic earns FDA breakthrough device designation
Amphix Bio earned FDA breakthrough device designation for a bone regeneration drug-device combination, according to an Oct. 3 news release. -
Enovis, Ossium Health partner on bone allograft distribution
Medical technology company Enovis is partnering with Ossium Health to distribute viable bone matrix allografts. -
Altus Spine and Joint Pain Center partners with biologics company
McAllen, Texas-based Altus Spine and Joint Pain Center partnered with Regenexx to provide noninvasive regenerative medicine services for orthopedic patients. -
Orthopedic leader named to board of Mayo Clinic spinoff
Rion, a regenerative medicine company, named five leaders to its advisory board, according to a Sept. 25 news release. -
Study supports biologic for spine patients with cancer
Zetagen Therapeutics' ZetaFuse has potential to treat degenerative disc disease in patients with late-stage cancer, according to a case study in the Journal of the American Academy of Orthopaedic Surgeons. -
Cerapedics' spinal bone graft earns approval for ACDF
Cerapedics earned FDA approval to expand the use of its spinal fusion biologic, i-Factor P-15, according to a Sept. 24 news release. -
5 spine, orthopedic biologics companies to know
Here are five companies making spine and orthopedic biologic products: -
Biologic injection may not be beneficial for meniscectomy: 5 notes
Bone marrow aspirate injections didn't lead to significant changes for patients who had arthroscopic partial meniscectomy, according to a Sept. 15 study in The American Journal of Sports Medicine. -
Spine biologics with the most research potential
Spine biologics is a realm ripe for exploration of its potential and applications in patient care. -
The most underutilized spine biologics
Regenerative medicine in spine surgery is on the rise, and there are many biologic tools that physicians say could be used more in the field.
Page 1 of 36